Recommended

Lilly to sell Branchburg site as its global manufacturing plans take shape
Bristol Myers Squibb names new Head of Development
Sanofi strikes $1.6 bn respiratory vaccine deal
Lilly’s Alzheimer’s drug demonstrates long-term benefit
Amid FDA turmoil Sarepta’s gene therapy worries begin to ease
Decentralised manufacturing world-first with new UK legislation
Key trends shaping the pharma landscape in Q3 2025
Transforming pharma manufacturing with digital tools
webinar

The path forward — Altasciences’ approach to project management

9 March 2022

Shares

10

Discover the opportunities Altasciences’ hybrid approach to project management can offer your drug development programme.

About this on-demand webinar

Altasciences offers a unique approach that can lower your costs and reduce programme timelines from lead candidate selection to clinical proof-of-concept by up to 40 percent.

A significant piece of this offering is the development and implementation of project and programme management. By working in close collaboration with key internal and external stakeholders, project and programme managers ensure seamless and timely communications with sponsors and synchronised workflows between departments and sites.

This webinar will focus on the opportunities our hybrid approach can offer your drug development program.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

Learning outcomes

  • The difference between project and programme management
  • How Altasciences’ programme management approach is unique
  • The benefits of involving project management in IND- and NDA-enabling packages of non-clinical studies, including specific case studies
  • Altasciences’ commitment to Tell Us OnceTM, including real-life experiences and feedback from our clients

Our speakers

Lauren SzczurowskiLauren Szczurowski, Vice President, Scientific Project Management, Altasciences

Lauren Szczurowski, Vice President, Scientific Project Management, joined Altasciences in 2017 and has approximately 20 years of clinical trial management experience, including 10 years in departmental leadership and strategic growth. She began her career in early development managing Phase I/IIb multi-centre studies in healthy volunteers and patient populations, with a focus on CNS and infectious diseases. Prior to joining Altasciences, she was responsible for a team of clinical trial managers, overseeing more than 30 multi-centre global oncology trials ranging from Phase I to Phase III. A strategic and tactical leader, Lauren plays a significant role in driving Altasciences’ growth by managing team and system integrations and successful collaborations across the organisation.

melanie barthMelanie Barth, Associate Director, Scientific Project Management, Altasciences

Melanie Barth, Associate Director, Scientific Project Management, has worked in early phase clinical research for over 20 years. She joined Altasciences in 2014 as Associate Director, Clinical Operations and subsequently moved over to the project management team in 2018.  Melanie has experience working on pre-clinical and clinical Phase I and IV studies. Her vast experience enables her to support a team of project managers and co-ordinators, using her problem-solving skills to execute projects efficiently and within budget. Melanie’s areas of expertise include training, site management, oversight of data services (data management, biostatistics, programming, clinical monitoring, and medical writing), and close collaboration with vendors.

Share via